Lassogen is Drug Discovery in United States that focus on potent biological activity business. Founded in 2019. They cover business area such as developer, lasso peptide, disease, distinctive lasso, topology, these scaffold, beneficial property, potent biological activity, challenge drug-resistant gram-positive, gram-negative and mycobacterial pathogen, g protein-couple receptor, patient, intractable health challenge.
2019
( 7 years old in 2026 )
Potent Biological Activity
-
3030 Bunker Hill Street
Suite 220
San Diego, CA 92109
United States
Private
developerlasso peptidediseasedistinctive lassotopologythese scaffoldbeneficial propertypotent biological activitychallenge drug-resistant gram-positive, gram-negative and mycobacterial pathogeng protein-couple receptorpatientintractable health challenge
* We use standard office opening hours in near Lassogen's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Lassogen is Drug Discovery business from United States that founded in 2019 (7 years old in 2026), Lassogen business is focusing on Potent Biological Activity.
Lassogen headquarter office and corporate office address is located in 3030 Bunker Hill Street Suite 220 San Diego, CA 92109 United States.
Lassogen was founded in United States.
In 2026, Lassogen is currently focus on potent biological activity sector.
Above is snippet of Google Trends for "potent biological activity" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Lassogen, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
